Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia. - Wikidata - wikimedia - TriplyDB

Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.

Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.

http://www.wikidata.org/entity/Q37602513

about

Personalized medicine of patients with respiratory infections through the measurement of specific blood biomarkers: fact or fiction?The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation.

P2860

Q40174185-1735D213-6EAC-41A9-AF34-CB3BEC11E924 Q47662026-8523F182-46A9-4A68-BA12-2D068EC45C56

P2860

Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.

http://www.wikidata.org/entity/Q37602513

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Admission levels of asymmetric ...... community-acquired pneumonia.

@en

Admission levels of asymmetric ...... community-acquired pneumonia.

@nl

type

label

Admission levels of asymmetric ...... community-acquired pneumonia.

@en

Admission levels of asymmetric ...... community-acquired pneumonia.

@nl

prefLabel

Admission levels of asymmetric ...... community-acquired pneumonia.

@en

Admission levels of asymmetric ...... community-acquired pneumonia.

@nl

P1433

Q37602513-C6BAE2DB-45BB-4031-8A3C-1BC1E3F49CB6

P1476

Q37602513-FFA8542C-8E7F-4CA0-B2D6-91C89BBFC07D

P2093

Q37602513-2860A0CE-0F01-4AA7-9FFF-242A09982CDA

Q37602513-33159B58-A8D2-4437-956B-DA0B6D679303

Q37602513-3E896D9D-1EC9-4079-86F3-F180F8E44C7A

Q37602513-442207B5-5389-4BCB-A403-BED45C07AA71

Q37602513-44568785-40A6-4ED0-AFF1-1CE9A70872DB

Q37602513-4A8E6471-FF7F-4132-9119-A26ECC6CB427

Q37602513-52512AF4-5F46-401B-ABB2-80930C7B61B0

Q37602513-915F0B26-CF1D-4823-AB91-AB65A9CA5F8F

Q37602513-A8E8E4E1-F79B-4EE6-A705-10C4D74EAC7E

Q37602513-BF723F12-E9BB-4771-9948-2149F683535F

P2860

Q37602513-0183113A-702B-4AFA-9A4F-9833D22CA39B

Q37602513-0558F227-8FD0-4D01-851A-4B0E35B5974A

Q37602513-0A60F589-2E7D-4DEC-80C5-E2C6F5F19913

Q37602513-1EE66A45-7785-48CE-90E0-8A1B93833287

Q37602513-2918F6FF-C0F0-425B-B95C-41E471872E21

Q37602513-3618131A-EE86-4FF5-A4F8-0CB9C0619F32

Q37602513-36777836-E655-4B7D-9D3F-74A672BACB2B

Q37602513-3D764544-DEAE-4A7C-ABA9-1AD16E2626C0

Q37602513-4069E543-54E0-4FED-ACA6-3EFFAAC2819D

Q37602513-41175AF0-1E85-4126-9BF9-9D2B8082C083

P2888

Q37602513-8FF177EA-088C-412F-A1EE-AB3589F9D3CD

P304

Q37602513-28958957-F76F-49CE-9E8C-501E345A0301

P31

Q37602513-17B15D23-404A-491E-911C-E15BFE58B9B4

P356

Q37602513-2199C7FC-426C-45C7-8B58-0E3F3AB748DD

P433

Q37602513-6F45146F-2738-461A-A152-DA4ADAC319D1

P478

Q37602513-7C8E7010-C73B-4C53-B65D-9497FA658576

P50

Q37602513-07B6DB9E-D911-4EC8-AE77-BC7F79C295E1

Q37602513-C9006E03-D1CC-4562-905A-AE26890651DC

P577

Q37602513-18BA5F53-FAA5-4341-A25F-3C11478246A1

P6179

Q37602513-4EFFAF0A-FF90-4304-82DC-A9DF6422FEBF

P698

Q37602513-1F9851DA-8742-4A34-A5CB-6B9A9F1DD819

P921

Q37602513-96EE1FB4-3193-48D2-8458-B2D2E3200F63

P932

Q37602513-BE15B3CF-A329-48CD-A9E1-620D65E41471

P356

S12931-017-0502-4

P1433

Respiratory Research

P1476

Admission levels of asymmetric ...... community-acquired pneumonia.

@en

P2093

Alaadin Vögeli

http://www.w3.org/2001/XMLSchema#string

Andreas Huber

http://www.w3.org/2001/XMLSchema#string

Beat Mueller

http://www.w3.org/2001/XMLSchema#string

Christoph Henzen

http://www.w3.org/2001/XMLSchema#string

Claus Hoess

http://www.w3.org/2001/XMLSchema#string

Luca Bernasconi

http://www.w3.org/2001/XMLSchema#string

Manuel Ottiger

http://www.w3.org/2001/XMLSchema#string

Marc A Meier

http://www.w3.org/2001/XMLSchema#string

Philipp Schuetz

http://www.w3.org/2001/XMLSchema#string

Prasad Kulkarni

http://www.w3.org/2001/XMLSchema#string

P2860

The L-arginine-nitric oxide pathway

Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections

Arginase and pulmonary diseases

Genetic Influences on Metabolite Levels: A Comparison across Metabolomic Platforms

Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.

Asymmetric dimethylarginine in chronic obstructive pulmonary disease (ADMA in COPD)

ADMA/SDMA in elderly subjects with asymptomatic carotid atherosclerosis: values and site-specific association.

The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease

A genome-wide perspective of genetic variation in human metabolism.

Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile

P2888

s12931-017-0502-4

P304

25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12931-017-0502-4

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Christian Steuer

Mirjam Christ-Crain

P577

2017-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1074213902

http://www.w3.org/2001/XMLSchema#string

P698

28114935

http://www.w3.org/2001/XMLSchema#string

P921

P932

5259979

http://www.w3.org/2001/XMLSchema#string